DPP-4 inhibitors for the treatment of type 2 diabetes: a methodology overview of systematic reviews

被引：0
|
作者：
Juan Ling
Long Ge
Ding-hua Zhang
Yong-feng Wang
Zhuo-lin Xie
Jin-hui Tian
Xiao-hui Xiao
Ke-hu Yang
机构：
[1] Lanzhou University,School of Basic Medical Sciences, Evidence
[2] Key Laboratory of Evidence Based Medicine and Knowledge Translation of Gansu Province,Based Medicine Center
[3] Lanzhou University,Chinese GRADE Center
[4] WHO Collaborating Center for Guideline Implementation and Knowledge Translation,School of Basic Medical Sciences
[5] The First Clinical Medical College of Lanzhou University,Department of Endocrinology
[6] Gansu University of Traditional Chinese Medicine,undefined
[7] Gansu University of Traditional Chinese Medicine,undefined
[8] Gansu Province Hospital of Traditional Chinese Medicine,undefined
[9] Gansu Provincial People’s Hospital,undefined
来源：
Acta Diabetologica | 2019年 / 56卷
关键词：
Dipeptidyl peptidase 4 inhibitors; Systematic reviews; Type 2 diabetes mellitus; AMSTAR; GRADE;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：7 / 27
页数：20
相关论文
共 50 条
  • [21] Reporting and methodological quality of systematic reviews of DPP-4 inhibitors for patients with type 2 diabetes mellitus: an evidence-based mapping
    Zouxi Du
    Tingting Lu
    Mingdong Gao
    Limin Tian
    Acta Diabetologica, 2022, 59 : 1539 - 1549
  • [22] THE PLACE OF DPP-4 INHIBITORS IN THE TREATMENT ALGORITHM OF DIABETES TYPE 2: A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS STUDIES
    Baptista, A.
    Teixeira, I
    Romano, S.
    Carneiro, Vaz A.
    Perelman, J.
    VALUE IN HEALTH, 2014, 17 (07) : A347 - A347
  • [23] The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies
    Alexandre Baptista
    Inês Teixeira
    Sónia Romano
    António Vaz Carneiro
    Julian Perelman
    The European Journal of Health Economics, 2017, 18 : 937 - 965
  • [24] The place of DPP-4 inhibitors in the treatment algorithm of diabetes type 2: a systematic review of cost-effectiveness studies
    Baptista, Alexandre
    Teixeira, Ines
    Romano, Sonia
    Carneiro, Antonio Vaz
    Perelman, Julian
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2017, 18 (08): : 937 - 965
  • [25] Efficacy of DPP-4 inhibitors and predictive factor for the treatment in patients with type 2 diabetes mellitus
    Hahm, J. R.
    Lee, S. M.
    Jung, T. S.
    Jung, J. H.
    Chung, S. I.
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2012, 28 : 103 - 103
  • [26] DPP-4 inhibitors treatment in Chinese type 2 diabetes patients: A meta-analysis
    Cai, Xiaoling
    Gao, Xueying
    Yang, Wenjia
    Chen, Yifei
    Zhou, Lingli
    Han, Xueyao
    Ji, Linong
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S104 - S104
  • [27] Looking to the future - Focus on DPP-4 inhibitors for the treatment of type 2 diabetes and emerging therapies
    Neumiller, Joshua J.
    Odegard, Peggy Soule
    White, John R., Jr.
    Setter, Stephen M.
    Campbell, R. Keith
    DIABETES EDUCATOR, 2008, 34 (02): : 183 - +
  • [28] GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes
    Ahrén, B
    Schmitz, O
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 867 - 876
  • [29] Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment
    Merlin C. Thomas
    Päivi M. Paldánius
    Rajeev Ayyagari
    Siew Hwa Ong
    Per-Henrik Groop
    Diabetes Therapy, 2016, 7 : 439 - 454
  • [30] Systematic Literature Review of DPP-4 Inhibitors in Patients with Type 2 Diabetes Mellitus and Renal Impairment
    Thomas, Merlin C.
    Paldanius, Paivi M.
    Ayyagari, Rajeev
    Ong, Siew Hwa
    Groop, Per-Henrik
    DIABETES THERAPY, 2016, 7 (03) : 439 - 454
12345